Ivermectina en ectoparasitosis infantil
Palabras clave:
Pediculosis capitis, Ivermectina, GABAResumen
La pediculosis capitis es la enfermedad más prevalente entre los niños sumando más casos que todas las demás enfermedades comunicables de la niñez. Este estudio demuestra la utilidad y la seguridad de la ivennectina en pediculosis capitis en niños de 14 años de edad, mediante un tratamiento de fácil administración, por vía oral, de una sola dosis, prácticamente atóxico, sin efectos colaterales de bajo costo y con alta tasa de curación (97% con una dosis y
100% con dos dosis).
La Ivermectina paraliza nemátodos y artrópodos estimulando la conductancia del cloro mediada por el GABA, bloqueando la transmisión post sináptica de los impulsos nerviosos, dando como resultado que el parásito se paralice y muera.
Referencias bibliográficas
Youssef-MY, Suduku-HA Eissa-MM, et al. Topical application o! ivermectin for human ectoparasites. Am J Trop, Med, Hyg. 1995; 53(6): 652-3.
https://doi.org/10.4269/ajtmh.1995.53.652
Currie BJ., M re-GP Wood-Yk. Ivernectin and crusted (Norwegian) scabies [letter]. Med J, Aust, 1995; 163(10): 5559-60.
https://doi.org/10.5694/j.1326-5377.1995.tb124745.x
JenickT, Nothdurft-HD, Rieder-N, LoscherT. Cutaneous myiasis reviewoIT3cases in travelers returning from tropical countries Int J Dermatol, 1995; 34(9); 624-6.
https://doi.org/10.1111/j.1365-4362.1995.tb01088.x
Okello-DO, Ovuga-EB, Ogwal-Okcng JW. Dennatological problems oí onchocerciasis in Nebbi District, Uganda. East Air Med J 1995; 72(5):295-8.
Baraka OZ, Mahmoud-BM, Ali-MM, Alí-MM, et al. Ivermectin trealment in severe asynumetric reactive onchodermatitis (sowda) in Sudan. Trans R Soc Trop Med Hyg. 1995; 89(3): 312-5.
https://doi.org/10.1016/0035-9203(95)90559-6
Meinking TL, Taplin D; Hermida JL, Pardo R, et al. The treatment of scabies with ivermectin, N Engl J Med. 1995; 333(1); 26-30.
https://doi.org/10.1056/NEJM199507063330105
Rodríguez Peréz MA, Rodíguez MH, Margeli Perez HM; et al. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin, ocular lesions, and infectivity of simulium ochraceum populations in southern Mexico, Am J Trop Med Hyg. 1995; 52(5):429-34
Burnham, G. Ivermectin treatment of onchocercal skin lesions: observation from a placebo controlled, double-blind trial in Malawi. Am J Trop Med Hyg. 1995; 52(3): 270-6.
https://doi.org/10.4269/ajtmh.52-270
Aubin , K, Humbert, R Ivermectin for crusted (Norwegian) scabies [letter] N Engl J Med. 1995; 332(9): 612.
https://doi.org/10.1056/NEJM199503023320917
Sieghart, W.: Structure and pharmacology of Gamma Aminobutyric Acid A Receptor subtypes. Pharmacogical Reviews. 1995; 47(2): 181-231.
Glazoiu P, Nyguyen,L.N., Moulia-Pelat, J. Petal.: Efficacy of ivermectin for the treatmen of head lice (Pediculosis capitis). Trop Med Parasitol. 1994; 45(3): 253-4.
Alley, E.S., Plaiser, A.R, Boatin , B.A., Dadzie K.Y., et al.: The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg. 1994; 88 (5). 581-4.
https://doi.org/10.1016/0035-9203(94)90172-4
Marty-R Gari-Toussaint M, Le Eichoux Y, Gitxotte P, Efficacy of ivermectin in the treatment of an epidémica of sarcoptic seabies. Ann Trop Med-Parasitol. 1994; 88(4):453.
https://doi.org/10.1080/00034983.1994.11812890
Caumes E, Datry A, Mayorga R, et al. Efficacy of ivermectin in the therapy of larva currens [letter]. Arch Dermatol. 1994; 130(7); 932.
https://doi.org/10.1001/archderm.1994.01690070128022
Kar Sk ; Mania J; Patnaik S. The use of ivermectin for scabies. Natl Med J. India. (1994; 7(1); 15-6.
Macotela Ruiz E; Peña-González G. Tratamiento de la escabiasis con ivermectina por via oral, Gac Med. Mex. 1993; 129(3): 201-5.
Glazou P, Cartel. JL, Alzieu P, et al. Comparison of ivermectin and benzyl benzoate for tretament of scabies. Trop Med Parasitol. 1993: 120(S): 571-3.
Caumes E; Gentilini M Traitement de la larva migrans cutanee ankykistimienne. Ann Dermatol Venereol. 1993; 120(8) : 571-3.
Carriere-E, Carriere J, Datry A, et al. Arandomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop-Med-Hvg. 1993;49(5); 641-4.
https://doi.org/10.4269/ajtmh.1993.49.641
Wolf P, Ochsendorf FR, Milbradt R, Aktuelle Therapiemoglichkeiten bei larva migrans cutanea. Hautarzt, 1993; 44(7): 462-5.
Young PN, Traore S, Wanu S, et al. Ivermectin in human onchocerciasis: a clinical patologiad study of skin lesions before and three days after treatmen. Ann Parasitol Hum Comp. 1992; 67(6): 194-6.
https://doi.org/10.1051/parasite/1992676194
Louis FJ; de Quincenet G; Louis JP. Internet de l'ivermectine en prise unique dans le traitement du syndrome de larva migrans cutanee. Presse-Med. 1992; 21(31): 1483.
Chijioke CP, Okonkwo PO . Adverse events following mass ivemectin therapy for onehocerciasis. Trans R Soc Trop Med Hyg 1992; 86(3):284-6.
https://doi.org/10.1016/0035-9203(92)90310-9
Collins RC, Gonzalez Peralta C, Castro J, et al. Ivermectin: reduction in prevalence and infection intensity of Onchocerce volvulus following biannual treatments in five Guatemalan communictis. Am J Trop Med Hyg. 1992; 47(2)156-69.
https://doi.org/10.4269/ajtmh.1992.47.156
Caumes-E, Datry A, Paris L, et al. Efficacy of ivermectin in the therapy of cutaneous larva migrans [letter]. Arch Dermatol. 1992; 128(7): 994-5.
https://doi.org/10.1001/archderm.1992.01680170130027
Dunne CL, Malone CJ, Whitworth JA. A field study of the effects of ivermectin on ectoparasites of man Trans R Soc Trop Med Hyg. 1991, 35(4):550-1
https://doi.org/10.1016/0035-9203(91)90255-W
Pacque M, Greene BM, Muñoz B, Taylor HR, Ivermectin therapy: a 5 year follow up [letter]. J Infect Dis. 1991; 164(5); 1035-6.
https://doi.org/10.1093/infdis/164.5.1035
Pacque M, Elmets C, Dukuly-ZD, Muñoz B, et al. improvement in severe onchocercal skin disease after a single dose if ivermectin. Am J Med. 1991; 90(5): 590-4.
https://doi.org/10.1016/S0002-9343(05)80010-5
Mumcuogh KY, Miller J, Rosen LJ, Galun R. Systemic activity of ivermectin on the human body louse (Anoplura: Pediculidae). J Med-Entomol. 1990 Jan; 27(l):72-5.
https://doi.org/10.1093/jmedent/27.1.72
Maso MJ, Kapila R, Schwartz RA, et al, Cutaneous onchocerciasis. Int J Dermatol. 1987; 26(9):593-6.
https://doi.org/10.1111/j.1365-4362.1987.tb02313.x
Olsen, R.W., Snowman A.M.; Avermectin Bla modulation of gamma aminobutyric acid / benzodiazepine receptor binding in mammalian brain. J. Neuochem 1985; 44:1074-82.
https://doi.org/10.1111/j.1471-4159.1985.tb08727.x
Pong, S.S., Wang, C.C. The specificity of high affinity binding of avermectin Bla to mammalian brain. Neuropharmacology 1980; 19:311-17.
https://doi.org/10.1016/0028-3908(80)90155-0
Rennet, D.G. Clinical pharmacology of ivermectin. JAVMA., 1986; 189:100-3.
Cómo citar
Descargas
Descargas
Publicado
Cómo citar
Número
Sección
Estadísticas de artículo | |
---|---|
Vistas de resúmenes | |
Vistas de PDF | |
Descargas de PDF | |
Vistas de HTML | |
Otras vistas |